Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page header/footer software revision was updated from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov site release rather than modifying the study record details.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check56 days agoChange Detected- Revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page shows a revision update from v3.4.2 to v3.4.3, with no changes to the study details.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.4.2 was added and the previous v3.4.1 funding notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check99 days agoChange DetectedA general government funding notice and a minor site revision (Revision: v3.4.1) were added; these changes do not affect study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.